Hedrington, Maka S: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Oral semaglutide for the treatment of type 2 diabetes

Hedrington, Maka S., Davis, Stephen N.

Journal:

Expert Opinion on Pharmacotherapy

Year:

2018

Language:

english

File:

PDF, 990 KB

english, 2018

2

Subcutaneous semaglutide (NN9535) for the treatment of type 2 diabetes

Hedrington, Maka S, Tsiskarishvili, Ana, Davis, Stephen N

Journal:

Expert Opinion on Biological Therapy

Year:

2018

Language:

english

File:

PDF, 1.14 MB

english, 2018

3

An update on the safety and efficacy of oral antidiabetic drugs: DPP-4 inhibitors and SGLT-2 inhibitors

Lamos, Elizabeth Mary, Hedrington, Maka, Davis, Stephen N

Journal:

Expert Opinion on Drug Safety

Year:

2019

Language:

english

File:

PDF, 1.22 MB

english, 2019

4

Discontinued in 2013: diabetic drugs

Hedrington, Maka S, Davis, Stephen N

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 254 KB

english, 2014

5

Basal Insulin Treatment in Type 2 Diabetes

Hedrington, Maka S., Pulliam, Lindsay, Davis, Stephen N.

Journal:

Diabetes Technology & Therapeutics

Year:

2011

Language:

english

File:

PDF, 219 KB

english, 2011

6

Ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, in the treatment of type 2 diabetes

Hedrington, Maka S, Davis, Stephen N

Journal:

Expert Opinion on Drug Metabolism & Toxicology

Year:

2015

Language:

english

File:

PDF, 313 KB

english, 2015

7

Effect of GABA A receptor activation on counterregulatory responses to subsequent exercise in individuals with type 1 diabetes

Hedrington, Maka S., Mikeladze, Maia, Tate, Donna B., Younk, Lisa M., Davis, Ian, Davis, Stephen N.

Journal:

Year:

2016

Language:

english

File:

PDF, 356 KB

english, 2016

8

Acute effects of oral Dehydroepiandrosterone on counterregulatory responses during repeated hypoglycemia in healthy humans

Mikeladze, Maia, Hedrington, Maka S., Joy, Nino, Tate, Donna B., Younk, Lisa M., Davis, Ian, Davis, Stephen N.

Journal:

Year:

2016

Language:

english

File:

PDF, 335 KB

english, 2016

9

Discontinued drug therapies to treat diabetes in 2015

Hedrington, Maka S., Davis, Stephen N.

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 658 KB

english, 2017

10

The care of pregestational and gestational diabetes and drug metabolism considerations

Hedrington, Maka S, Davis, Stephen N.

Journal:

Expert Opinion on Drug Metabolism & Toxicology

Year:

2017

Language:

english

File:

PDF, 1.11 MB

english, 2017

11

Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver

Hedrington, Maka S., Davis, Stephen N.

Journal:

Expert Opinion on Drug Metabolism & Toxicology

Year:

2018

Language:

english

File:

PDF, 991 KB

english, 2018

12

Sexual Dimorphism in Glucose and Lipid Metabolism during Fasting, Hypoglycemia, and Exercise

Hedrington, Maka S., Davis, Stephen N.

Journal:

Frontiers in Endocrinology

Year:

2015

Language:

english

File:

PDF, 1.77 MB

english, 2015

13

The role of empagliflozin in the management of type 2 diabetes by patient profile

Davis, Stephen, Hedrington, Maka

Journal:

Therapeutics and Clinical Risk Management

Year:

2015

Language:

english

File:

PDF, 799 KB

english, 2015

14

Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes

Hedrington, Maka S., Davis, Stephen N.

Journal:

Expert Opinion on Pharmacotherapy

Year:

2019

Language:

english

File:

PDF, 831 KB

english, 2019